AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 4%
#5084 out of 5266 analysts
Average Return
-10.32%
Win Rate
45%24 out of 53
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +159.60% | $1.98 | $5.14 | 2025-10-29 - 2026-05-01 | Buy |
Moonlake ImmunotherapeuticsMLTX | +133.33% | $7.17 | $16.73 | 2025-09-30 - 2026-05-01 | Buy |
Camp4 Therapeutics CorpCAMP | +103.52% | $1.99 | $4.05 | 2025-05-27 - 2026-05-01 | Buy |
Protagonist Therapeutics IncPTGX | +102.48% | $48.88 | $98.97 | 2025-03-28 - 2026-03-27 | Buy |
Tectonic Therapeutic IncTECX | +77.07% | $9.42 | $16.68 | 2022-12-08 - 2023-12-07 | Strong Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Passage Bio IncPASG | 4 | Hold | $8.00 | +60.97% | Downgrades | 12 days ago |
Ascendis Pharma AASND | 5 | Buy | $273.00 | +23.57% | Reiterates | 24 days ago |
Rezolute IncRZLT | 3 | Buy | $5.00 | +51.52% | Upgrades | a month ago |
Opus Genetics IncIRD | 2 | Buy | $10.00 | +94.55% | Maintains | 2 months ago |
Wave Life Sciences LtdWVE | 4 | Buy | $35.00 | +378.14% | Maintains | 2 months ago |
Mannkind CorpMNKD | 1 | Buy | $8.00 | +181.69% | Maintains | 2 months ago |
Sarepta Therapeutics IncSRPT | 6 | Buy | $34.00 | +58.21% | Maintains | 3 months ago |
Keros Therapeutics IncKROS | 3 | Hold | $16.00 | +39.25% | Maintains | 6 months ago |
Protagonist Therapeutics IncPTGX | 3 | Buy | $86.00 | -12.57% | Maintains | 6 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $18.00 | +7.59% | Maintains | 7 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $28.00 | +267.94% | Initiates Coverage On | 9 months ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $8.00 | +112.77% | Maintains | 9 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | +97.53% | Initiates Coverage On | a year ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | +798.88% | Reiterates | a year ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 4 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 5 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 5 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 5 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.